{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:46:24Z","timestamp":1795189584879,"version":"4.10.3"},"reference-count":23,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Upadacitinib (UPA) is a new oral selective Janus Kinase (JAK) inhibitor that has shown high efficacy in the treatment of ulcerative colitis (UC). We present data from a multicenter real-world study. Methods: To assess efficacy of UPA, Total Mayo Score (TMS), fecal calprotectin (FC), endoscopy, and intestinal ultrasonography (IUS) were performed. Results: The study population included 76 patients. An amount of 26.3% of the patients were biologics and small molecules-naive, while 73.7% were exposed. By Week 8, 93.4% of the patients had achieved a clinical response (94.7% naive vs. 92.9% exposed), 72.4% achieved endoscopic improvement (78.9% vs. 71.4%), and 57.9% had clinical remission (78.9% vs. 51.8%). Endoscopic remission was achieved in 31.6% of patients (35.0% vs. 30.4%) and biochemical remission in 82.1% (53.3% vs. 68.3%). All of the results were not significantly different apart from the steroid-free clinical remission\u201436.8% (68% vs. 26.8%, p = 0.002) after 8 weeks of follow-up. IUS was performed in 33 patients. Bowel wall thickness (BWT), inflammatory fat (iFAT), color Doppler signal (CDS), loss of bowel wall stratification (BWS), and Milano Ultrasound Criteria (MUC) had decreased significantly by Weeks 4 and 8 (p &lt; 0.005 for all). Correlation between the IUS results and TMS, FC and endoscopic remission in Week 8 was confirmed (p &lt; 0.001). UPA was well tolerated, and no new safety signals were registered in our group. Conclusions: In this study, UPA was confirmed to be safe and highly effective in inducing remission in UC patients in both the naive group and the biologically exposed patients. The correlation between the IUS results and TMS, FC, and endoscopic remission provides valuable information for clinicians.<\/jats:p>","DOI":"10.3390\/jcm14051695","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T07:37:17Z","timestamp":1740987437000},"page":"1695","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Magdalena","family":"Kaniewska","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, National Medical Institute of the Ministry of the Inferior and Administration, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-4905","authenticated-orcid":false,"given":"Konrad","family":"Lewandowski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, National Medical Institute of the Ministry of the Inferior and Administration, 02-507 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-7652","authenticated-orcid":false,"given":"Micha\u0142","family":"Krogulecki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Military Institute of Medicine, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6700-2719","authenticated-orcid":false,"given":"Aleksandra","family":"Filipiuk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Military Institute of Medicine, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Gonciarz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Military Institute of Medicine, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9394-4470","authenticated-orcid":false,"given":"Anna","family":"Pietrzak","sequence":"additional","affiliation":[{"name":"II Gastroenterology Department, Centre of Postgraduate Medical Education, 00-416 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-3128","authenticated-orcid":false,"given":"Maria","family":"Janiak","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Medical University of Gdansk, 80-210 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6476-9095","authenticated-orcid":false,"given":"Krystian","family":"Adrych","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Medical University of Gdansk, 80-210 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Klufczynska","sequence":"additional","affiliation":[{"name":"Clinical Hospital of the Ministry of the Interior and Administration, 80-952 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Piotrowicz","sequence":"additional","affiliation":[{"name":"Clinical Hospital of the Ministry of the Interior and Administration, 80-952 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-2720","authenticated-orcid":false,"given":"Maria","family":"Kopertowska-Majchrzak","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, General Hospital, 64-400 Miedzychod, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4629-3879","authenticated-orcid":false,"given":"Anatol","family":"Panasiuk","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases and Gastroenterology, Provincial Welded Hospital in Bialystok, 15-950 Bialystok, Poland"},{"name":"Department of Clinical Medicine, Medical University of Bialystok, 15-254 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-0318","authenticated-orcid":false,"given":"Dagmara","family":"Mahadea","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dietetics, and Internal Diseases, Poznan University of Medical Sciences, University Clinical Hospital, 61-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9306-5038","authenticated-orcid":false,"given":"Piotr","family":"Eder","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Dietetics, and Internal Diseases, Poznan University of Medical Sciences, University Clinical Hospital, 61-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Tarasiuk","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Gastroenterology, and Internal Medicine, Medical University of Bialystok Clinical Hospital, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3563-6215","authenticated-orcid":false,"given":"Mariusz","family":"Roso\u0142owski","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Gastroenterology, and Internal Medicine, Medical University of Bialystok Clinical Hospital, 15-089 Bialystok, Poland"},{"name":"Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Talar-Wojnarowska","sequence":"additional","affiliation":[{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1825-1807","authenticated-orcid":false,"given":"Ewa","family":"Ma\u0142ecka-Wojciesko","sequence":"additional","affiliation":[{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Liebert","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Nutritional Disorders, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 87-100 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-5826","authenticated-orcid":false,"given":"Maria","family":"K\u0142opocka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Nutritional Disorders, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 87-100 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Walecka-Kapica","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-3721","authenticated-orcid":false,"given":"Anita","family":"G\u0105siorowska","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Gali\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, J. Gromkowski Provincial Hospital, 51-149 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Le\u015bniakowski","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, J. Gromkowski Provincial Hospital, 51-149 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4171-2103","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Zwoli\u0144ska-Wcis\u0142o","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Jagiellonian University Medical College, 31-008 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Naumowicz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-1461","authenticated-orcid":false,"given":"Jaros\u0142aw","family":"Daniluk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Rydzewska","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, National Medical Institute of the Ministry of the Inferior and Administration, 02-507 Warsaw, Poland"},{"name":"Collegium Medicum, Jan Kochanowski University, 25-369 Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/pg.2023.125882","article-title":"Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology","volume":"18","author":"Eder","year":"2023","journal-title":"Gastroenterol. Rev.\/Przegl\u0105d Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5114\/pg.2021.110914","article-title":"Guidelines for the management of patients with Crohn\u2019s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology","volume":"16","author":"Eder","year":"2021","journal-title":"Gastroenterol. Rev.\/Przegl\u0105d Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1053\/j.gastro.2022.02.013","article-title":"Entering the era of disease modification in inflammatory bowel disease","volume":"162","author":"Hart","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"OCTAVE Induction 1, OCTAVE Induction 2, and OCTAVE Sustain Investigators. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2468-1253(19)30414-5","article-title":"Small molecule oral targeted therapies in ulcerative colitis","volume":"5","author":"Shivaji","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(21)00377-0","article-title":"Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: A systematic review and network meta-analysis","volume":"7","author":"Lasa","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s10620-019-05492-y","article-title":"Real-world experience with tofacitinib in IBD at a tertiary center","volume":"64","author":"Weisshof","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ecco-jcc\/jjaa145","article-title":"Tofacitinib in Ulcerative Colitis: Real-World Evidence from the ENEIDA Registry","volume":"15","author":"Chaparro","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wan, Z., Jin, R., Xu, T., Ouyang, Y., Wang, B., Ruan, G., and Bai, X. (2022). Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature review. Int. Immunopharmacol., 105.","DOI":"10.1016\/j.intimp.2022.108517"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","article-title":"ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease","volume":"18","author":"Gordon","year":"2024","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1053\/j.gastro.2021.09.078","article-title":"Breaking Through the Therapeutic Ceiling: What Will It Take?","volume":"162","author":"Raine","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Parmentier, J.M., Voss, J., Graff, C., Schwartz, A., Argiriadi, M., Friedman, M., Camp, H.S., Padley, R.J., George, J.S., and Hyland, D. (2018). In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494). BMC Rheumatol., 2.","DOI":"10.1186\/s41927-018-0031-x"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1053\/j.gastro.2020.02.030","article-title":"Efficacy of upadacitinib in a randomized trial of patients with active ulcerative colitis","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/annrheumdis-2020-218510","article-title":"Safety profile of upadacitinib in rheumatoid arthritis: Integrated analysis from the SELECT phase III clinical programme","volume":"80","author":"Cohen","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3748\/wjg.v29.i15.2272","article-title":"Intestinal ultrasound as a non-invasive tool to monitor inflammatory bowel disease activity and guide clinical decision making","volume":"29","author":"Dolinger","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/2050640620980203","article-title":"Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: External validation","volume":"9","author":"Allocca","year":"2021","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","article-title":"Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: Results from three phase 3, multicentre, double-blind, randomised trials","volume":"399","author":"Danese","year":"2022","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.cgh.2023.03.001","article-title":"Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn\u2019s Disease: Prospective Real-World Experience","volume":"21","author":"Friedberg","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/ibd\/izad155","article-title":"Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study","volume":"30","author":"Dalal","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.14309\/ajg.0000000000002674","article-title":"Effectiveness of Upadacitinib for Patients with Acute Severe Ulcerative Colitis: A Multicenter Experience","volume":"119","author":"Berinstein","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.cgh.2023.03.040","article-title":"Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data","volume":"21","author":"Boneschansker","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_22","first-page":"1992","article-title":"Early Intestinal Ultrasound Predicts Clinical and Endoscopic Treatment Response and Demonstrates Drug-Specific Kinetics in Moderate-to-Severe Ulcerative Colitis","volume":"30","author":"Bots","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1093\/ecco-jcc\/jjad115","article-title":"Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis","volume":"17","author":"Gilmore","year":"2023","journal-title":"J. Crohns Colitis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/5\/1695\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:46:20Z","timestamp":1760028380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/5\/1695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jcm14051695"],"URL":"https:\/\/doi.org\/10.3390\/jcm14051695","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}